
Photo story: GSK’s 2012 legacy
pharmafile | May 30, 2012 | Feature | Research and Development |Â Â Andrew Witty, GSK, Olympics 2012Â
Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters in Middlesex, London, to mark the partnership between GSK and Fields In Trust (FIT).
GSK has today entered a partnership with FIT to secure the future of local recreational space Swyncombe Avenue Playing Fields, Brentford, as part of FIT’s Queen Elizabeth II Fields Challenge, which seeks to protect 2,012 outdoor recreational areas across the UK as part of the legacy of London 2012 and The Diamond Jubilee.
Related Content

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis
GSK’s Exdensur (depemokimab), a twice-yearly biological medicine, has received approval from the UK Medicines and …

Multiple myeloma treatment approved in Japan
GSK’s Blenrep (belantamab mafodotin) combinations have been approved by Japan’s Ministry of Health, Labour and …

US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
PHILADELPHIA–GSK plc today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) in combination …





